Hundreds of English children under 12 prescribed GLP-1 weight-loss drugs

An investigation reveals that hundreds of children in England, including some under 12, are being prescribed GLP-1 medications for weight loss. Experts stress the need for specialist supervision and long-term monitoring, highlighting a potential gap in pediatric obesity care. This raises concerns about off-label use and long-term safety in minors.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works